Atlas Trials

Study to Investigate the Safety and Duration of Effect of Different Botulinum Toxin A (NT 201) Dose Groups Following the Treatment of Glabellar Frown Lines

Clinical trial NCT03806933 · COMPLETED

Trial details

NCT number
NCT03806933
Sponsor
Merz Aesthetics GmbH
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Moderate to Severe Glabellar Frown Lines
Start date
2019-01-23
Primary completion
2020-09-10
Enrollment
241

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.